Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
about
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: a randomized controlled trial in patients undergoing intra-arterial angiography (ANTI-CINRenal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat.Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritisUrinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary proceduresKIM-1 and NGAL: new markers of obstructive nephropathyNeutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis.Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndromeRenal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failurePlasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.Urinary Neutrophil Gelatinase-Associated Lipocalin to Monitor Lupus Nephritis Disease Activity.Pediatric reference ranges for acute kidney injury biomarkersComparison of Plasma and Urine Biomarker Performance in Acute Kidney Injury.Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) StudyPrognostic significance of urinary NGAL in chronic kidney disease.Urinary neutrophil gelatinase-associated lipocalin levels in comparison with glomerular filtration rate for evaluation of renal function in patients with diabetic chronic kidney disease.Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis.Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failureNeutrophil gelatinase-associated lipocalin as a biomarker of disease progression in patients with chronic kidney disease.Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in dogs with acute kidney injury or chronic kidney diseaseClinical review: Biomarkers of acute kidney injury: where are we now?Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.Novel Tubular Biomarkers Predict Renal Progression in Type 2 Diabetes Mellitus: A Prospective Cohort Study.Plasma NGAL for the diagnosis of AKI in patients admitted from the emergency department setting.Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal functionBiomarkers for lupus nephritis: a critical appraisal.Acute kidney injury in childhood: should we be worried about progression to CKD?Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.Neutrophil gelatinase associated lipocalin in acute kidney injury.Proteomic biomarkers in kidney disease: issues in development and implementation.Body fluid peptide and protein signatures in diabetic kidney diseases.Measuring Residual Renal Function in Hemodialysis Patients without Urine Collection.Do neutrophil gelatinase-associated lipocalin and interleukin-18 predict renal dysfunction in patients with familial Mediterranean fever and amyloidosis?Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction.Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis.Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury.
P2860
Q33646117-7BC0A1C9-472D-409C-A778-6122E8441626Q33945154-9E71C320-AB37-415D-8AFE-45576BFD5884Q33995274-B009AC1F-EFB6-447C-BC36-214E7A86C6D5Q34260466-893CFCE3-D4D1-4FC8-9606-C55F5F39F5DEQ34405352-DEF4622E-00B9-453B-9786-AB7FB0EDF717Q34523585-9069C7C3-4EF7-40F7-BADC-90DAC26A0B9BQ34594776-50C87A49-DDAB-4AD2-97BA-5F4A2B10E2E2Q34690957-0F4D744D-EF76-4D45-872F-F8C8FF409B69Q34720014-2376DA57-81B7-4611-B44F-1573C67E48B2Q34997491-CC23E3B9-DD2A-4A74-B0E4-B2EC65F74AE2Q35017352-1375292D-5F60-4D1D-B7A6-98A5D57D5925Q35626252-3ED084E5-7DDE-4AC7-839F-9223448D207DQ35626257-D683F928-A046-4196-92E7-E9EEADD38880Q35687846-C32766BF-EF02-4CE1-ACE5-EF9863946F02Q35784457-842D5351-BC1B-4B59-ABD1-D1A01B919D6CQ35857141-13499D8D-1856-42D2-B8FC-E66990B5884EQ35869088-BA924489-0654-48B9-83F5-9D7D76144EB8Q36103565-0EC42A11-F30A-47D3-B03C-7119CD31D366Q36177058-C22C136F-E2FB-489A-9DEF-F39DE00085D9Q36191746-3D873841-BCB8-4565-B75E-4D43FC09F544Q36210315-988ADBA3-6629-4503-B457-9E0B5AF8E933Q36315462-7FC00728-BFFD-4799-B6C7-D574B60587E4Q36696505-6B622453-7C46-4807-9D0F-C28B1086BAA0Q36873246-CE207E9B-483B-4D4C-BC25-C6C03F2A69B1Q36928048-B05EA65A-A053-44B9-A6F2-2BF819B358EBQ37087937-8F8D499F-8924-49DE-9116-4D262D6328EDQ37273724-8AC2C71F-CAED-4A63-B473-8CDE4FCB602DQ37359099-85C5B9EE-528C-4DEE-9062-62E59BE1226EQ37448863-3C3480C9-46B3-43FA-BC44-1293F0C13436Q37736277-449C8CFD-B751-4D07-9621-8B62A87A1A09Q37799323-98137D5E-7DEC-4F75-BF25-876223F25995Q38053941-BAA0BC54-3CEB-4D68-AE08-7E45CD662FD2Q38160639-40A27AB5-49A2-4745-AE89-8606406C8DB4Q38341211-1990B7E4-B51E-42E4-9ABB-4A58D80E7089Q38553924-6365C46C-0584-4232-9CF0-46BDAC06707AQ38985029-344F9062-CBE5-4B43-A071-BCD08AB0F6C4Q40225567-18FC5064-855A-4E02-B1E0-C85C78A894A3Q41106082-E04BA384-9E2F-4C6E-B623-0B90881D5DDBQ42112719-46116F55-3E85-427F-BD17-38E248967CF7Q43078917-C27C35C3-1A4C-4332-92C4-2844A4B918AC
P2860
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Neutrophil gelatinase-associat ...... ted by chronic kidney disease.
@en
type
label
Neutrophil gelatinase-associat ...... ted by chronic kidney disease.
@en
prefLabel
Neutrophil gelatinase-associat ...... ted by chronic kidney disease.
@en
P2093
P50
P356
P1476
Neutrophil gelatinase-associat ...... ted by chronic kidney disease.
@en
P2093
Adriana Arena
Michele Buemi
Susanna Campo
P304
P356
10.1159/000143726
P577
2008-07-05T00:00:00Z